News Releases 2015

RSS

21 DEC 2015 Nutraceuticals
Otsuka Pharmaceutical Concludes Cooperative Agreement to Maintain and Promote Healthy Lifestyles with Shiga Prefecture
7 DEC 2015 Pharmaceuticals
Winner Announced for the 2015 Young Innovator in TB Research Award
7 DEC 2015 Pharmaceuticals
Otsuka Files for Approval in Japan for an Additional Indication for the Antipsychotic ABILIFY: Excitability Associated with Juvenile Autism
4 DEC 2015 Nutraceuticals
Otsuka Pharmaceutical Concludes Comprehensive Agreement for Community Health Initiatives with Fukuoka Prefecture
1 DEC 2015 Nutraceuticals
POCARI SWEAT Launched in Cambodia on December 1, 2015
26 NOV 2015 Pharmaceuticals
E Keppra® Injectable, to be Launched in Japan on December 1; Will Contribute to Uninterrupted Treatment of Epilepsy Patients Aged 4 and Over with Partial-onset Seizures
17 NOV 2015 Pharmaceuticals
Otsuka Pharmaceutical Affiliate Avanir Pharmaceuticals Announces Initiation of Phase III Trial of AVP-786 for Agitation in Patients with Alzheimer’s Disease
16 NOV 2015 Nutraceuticals
Nature Made Ginkgo Biloba
Otsuka Pharmaceutical Introduces Japan’s First Food with Specific Function Claim for Cognitive Functions
16 NOV 2015 Corporate
10,000 Attend 7th Asan Walking Festival in Itano
on November 15
Cosponsored by Otsuka Pharmaceutical Tokushima Itano Factory

Go to the Top

7 OCT 2015 Nutraceuticals
Acquisition of BIOCENTURY,
Leading Spanish Health and Functional Food Company
1 OCT 2015 Nutraceuticals
Otsuka Pharmaceutical Named “Best Communicator”
‘Heatstroke Prevention Communication Project’ Hitosuzumi Awards 2015
1 OCT 2015 Pharmaceuticals
New Drug Application for Carteolol Hydrochloride/ Latanoprost, a Novel Combined Ophthalmic Solution, Submitted in Japan for the Treatment of Glaucoma and Ocular Hypertension
11 SEP 2015 Pharmaceuticals
U.S. FDA Accepts First Digital Medicine New Drug Application for
Otsuka and Proteus Digital Health
3 SEP 2015 Nutraceuticals
Three New SOYJOY Bars, Enhanced with More Fruit, More Flavor
Raisin, Apple and Hawthorn Berry
27 AUG 2015 Nutraceuticals
Three Nature Made Products Receive Foods with Function Claims
Labels specify benefits for eyes and inhibition of triglyceride levels in the blood
27 AUG 2015 Nutraceuticals
Omugi Gohan Barley Rice from OMUGI SEIKATSU Receive Food with Function Claims
Labels specify three benefits, including control of glucose absorption
13 AUG 2015 Pharmaceuticals
Otsuka Pharmaceutical’s Subsidiary Avanir Pharmaceuticals Prevails in NUEDEXTA® Patent Appeal Maintaining Exclusivity Through 2026 in the U.S.
6 AUG 2015 Nutraceuticals
New Pen-type UL•OS Medicated Skin Whitening Helps Men Avoid Dark Spots and Freckles by Inhibiting Melanin Formation
29 JUL 2015 Pharmaceuticals
Otsuka Pharmaceutical’s Subsidiary Astex Enters New Consortium for Drug Discovery Research at the University of Cambridge

Go to the Top

16 JUL 2015 Pharmaceuticals
Efficacy Results of Otsuka’s Delamanid (DeltybaTM) for Extensively Drug-Resistant Tuberculosis (XDR-TB) Published in the New England Journal of Medicine
13 JUL 2015 Pharmaceuticals
U.S. FDA Approves Otsuka and Lundbeck’s REXULTI® (brexpiprazole) as Adjunctive Treatment for Adults with Major Depressive Disorder and as a Treatment for Adults with Schizophrenia
1 JUL 2015 Nutraceuticals
Otsuka Pharmaceutical Continues the Overseas Distribution Expansion of POCARI SWEAT
East Timor Market Official Launch July 1, 2015
24 JUN 2015 Nutraceuticals
Otsuka Pharmaceutical Enters Into Health Promotion Partnership Agreement with Saitama Prefecture
23 JUN 2015 Nutraceuticals
Renovation of POCARI SWEAT Factory at Tianjin Otsuka Beverage Co., Ltd.
Visitor-friendly Factory Conveys the Importance of Ions and Fluid Replenishment
28 MAY 2015 Pharmaceuticals
Otsuka’s JINARC® the First-Ever Treatment Approved in Europe for Adults Living with ADPKD, a Chronic Genetic Kidney Disease
20 MAY 2015 Nutraceuticals
Overseas Distribution of ORONAMIN C DRINK
Expands to Hong Kong
Otsuka Pharmaceutical to Launch Carbonated Nutritional Beverage in Rapidly Growing Hong Kong Market
20 MAY 2015 Pharmaceuticals
New Treatment Option in Japan for People Living With Schizophrenia - Abilify for Extended-release Injectable Suspension, for Intramuscular Use, Launched on May 25
23 APR 2015 Nutraceuticals
Kenja-no-shokutaku Double Support
Makes Overseas Debut in Hong Kong
20 APR 2015 Pharmaceuticals
Results of Phase III Study of Brexpiprazole in Adult Patients with Schizophrenia Published in American Journal of Psychiatry

Go to the Top

Go to the Top

Go to the Top